PUBLISHER: Grand View Research | PRODUCT CODE: 1771509
PUBLISHER: Grand View Research | PRODUCT CODE: 1771509
The U.S. radiofrequency electrosurgery generators market size was valued at USD 346.62 million in 2024 and is expected to grow at a CAGR of 2.63% from 2025 to 2030. The rising number of surgical procedures, the rise of minimally invasive techniques, and advancements in electrosurgical technology are anticipated to drive the U.S. radiofrequency electrosurgery generators industry over the forecast period. According to the data published by Paras Health in January 2025, over 13 million laparoscopic procedures are performed globally each year. Such a large number of minimally invasive procedures and the availability of radiofrequency (RF) electrosurgery generators are anticipated to propel the market growth in the coming years.
Patients and healthcare providers increasingly prefer minimally invasive procedures for their numerous benefits, including faster recovery times, reduced pain, minimal scarring, and shorter hospital stays. These advantages are driving a global shift toward less invasive surgical techniques. Radiofrequency (RF) electrosurgery generators play a critical role in these procedures by enabling precise cutting and coagulation, thereby supporting the growing demand and market expansion for advanced surgical technologies.
Furthermore, many surgeries are now being performed using minimally invasive methods. According to the American Society of Plastic Surgeons (ASPS) 2023 report, minimally invasive procedures increased by 7% year-over-year, with over 25 million procedures performed. This surge highlights the growing preference for less invasive options in reconstructive and aesthetic surgery. The widespread use of RF electrosurgery generators in plastic and cosmetic procedures is expected to play a crucial role in sustaining this growth trajectory, driving further expansion of the RF electrosurgery generators market over the forecast period.
The increasing burden of chronic diseases, such as cancer, cardiovascular conditions, and neurological disorders, is a significant driver of growth in the radiofrequency (RF) electrosurgery generator market. These conditions often require surgical intervention, where precision and minimal tissue damage are critical. For instance, the RF 3000 Generator from Boston Scientific is designed explicitly for thermal coagulation and necrosis of soft tissues. It is commonly used for partial or complete ablation of nonresectable liver lesions, offering a minimally invasive treatment alternative. Thus, with the growing prevalence of chronic disorders, demand for radiofrequency electrosurgery generators is anticipated to increase significantly over the forecast period.
U.S. Radiofrequency Electrosurgery Generators Market Report Segmentation
This report forecasts revenue growth at regional and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the U.S. radiofrequency electrosurgery generators market report based on type, application, and end use.